Targeting Kinase Inhibitor Induced Signaling Plasticity in Patients with Ph-Like ALL,
Role: PD/PI,
National Institutes of Health/DHHS,
(03/2024 - 02/2026)
Status: Awarded
Non-Profit Organization
DYRK1A Inhibition Sensitizes SMARCA4 Mutated ALL Cells to Chemotherapy Drugs,
Role: PD/PI,
Alex's Lemonade Stand Foundation,
(06/2024 - 08/2024)
Status: Closed
Targeting Kinase Inhibitor DNA-Damage Response in Ph-Like ALL,
Role: PD/PI,
Alex's Lemonade Stand Foundation,
(02/2023 - 03/2028)
Status: Awarded